These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19538069)

  • 1. Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.
    Migliori GB; Sotgiu G; D'Arcy Richardson M; Centis R; Guenther G; Hoffmann H; Cirillo DM; Toungossova O; Kliiman K; De Lorenzo S; Spanevello A; Lange C;
    Clin Infect Dis; 2009 Jul; 49(2):315-6; author reply 317. PubMed ID: 19538069
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing extensively drug-resistant tuberculosis--a hope and a challenge.
    Raviglione MC
    N Engl J Med; 2008 Aug; 359(6):636-8. PubMed ID: 18687645
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment outcomes in extensively resistant tuberculosis.
    Chan ED; Strand MJ; Iseman MD
    N Engl J Med; 2008 Aug; 359(6):657-9. PubMed ID: 18687654
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of extensively drug-resistant tuberculosis.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):794; author reply 794-5. PubMed ID: 19460259
    [No Abstract]   [Full Text] [Related]  

  • 6. Death of a health care worker with nosocomial extensively drug-resistant tuberculosis in India.
    James P; Christopher DJ; Balamugesh T; Gupta R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):795-6. PubMed ID: 19460260
    [No Abstract]   [Full Text] [Related]  

  • 7. Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis.
    Chang KC; Leung CC; Tam CM
    Clin Infect Dis; 2009 Jun; 48(11):1632-3; author reply 1633-4. PubMed ID: 19416026
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrospective audit of patients treated for MDR-TB in re-treatment category.
    Saeed W; Naseem A; Ahmed J
    J Ayub Med Coll Abbottabad; 2009; 21(2):94-8. PubMed ID: 20524480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with pulmonary resection for extensively drug-resistant tuberculosis.
    Shiraishi Y; Katsuragi N; Kita H; Toishi M; Onda T
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1075-8. PubMed ID: 18812334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensively drug-resistant tuberculosis.
    Cheruvu M; Bhadriraju S
    N Engl J Med; 2008 Nov; 359(22):2390-1; author reply 2391. PubMed ID: 19051373
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
    Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensively drug resistance (XDR) tb is not always fatal.
    Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
    Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Schaaf HS; Willemse M; Donald PR
    Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On linezolid efficacy and tolerability.
    De Lorenzo S; Centis R; D'Ambrosio L; Sotgiu G; Migliori GB
    Eur Respir J; 2012 Mar; 39(3):770-2. PubMed ID: 22379150
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug resistant tuberculosis: a growing public health threat.
    Salahuddin N
    J Coll Physicians Surg Pak; 2009 Sep; 19(9):537-8. PubMed ID: 19728935
    [No Abstract]   [Full Text] [Related]  

  • 17. XDR Tuberculosis: a report from the New Delhi Tuberculosis Centre, India.
    Dhingra VK; Malik S; Hanif M; Arora VK
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):133-5. PubMed ID: 19208323
    [No Abstract]   [Full Text] [Related]  

  • 18. Delamanid for Extensively Drug-Resistant Tuberculosis.
    Gupta R; Geiter LJ; Wells CD; Gao M; Cirule A; Xiao H
    N Engl J Med; 2015 Jul; 373(3):291-2. PubMed ID: 26176402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Totally drug resistant tuberculosis?].
    Dahle UR
    Tidsskr Nor Laegeforen; 2012 Mar; 132(6):634. PubMed ID: 22456141
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of extensively drug-resistant tuberculosis.
    Silva JM; Fuchs SC; Barcellos NT; Zavascki AP
    Lancet; 2009 Jan; 373(9657):27; author reply 27-8. PubMed ID: 19121717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.